Loading...

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials

BACKGROUND: Prediction models for venous thromboembolism recurrence will likely be improved by adding levels of coagulation factors. Risk assessment is ideally performed during anticoagulant treatment, however, the influence of direct oral anticoagulants on coagulation factors is uncertain. OBJECTIV...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Res Pract Thromb Haemost
Main Authors: Scheres, Luuk J. J., Lijfering, Willem M., Middeldorp, Saskia, Cheung, Yuk W., Barco, Stefano, Cannegieter, Suzanne C., Coppens, Michiel
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178718/
https://ncbi.nlm.nih.gov/pubmed/30349888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12142
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!